Study guide
10.2 Glomerular & Tubulointerstitial Diseases
USMLE Step 2 CK Study Guide Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Human Development & Well-Patient Care
1.1 Infant, Child & Adolescent Development & Growth 1.2 Adult Development, Aging & Geriatric Assessment 1.3 Preventive Health, Immunization & Well-Patient Screening
2 Chapter 2: Immune System & Immunologic Disorders
2.1 Primary & Secondary Immunodeficiencies 2.2 Hypersensitivity Reactions, Allergy & Anaphylaxis 2.3 Autoimmune & Rheumatologic Disease Principles
3 Chapter 3: Blood & Lymphoreticular System
3.1 Anemias: Microcytic, Normocytic & Macrocytic Etiologies 3.2 Bleeding Disorders, Coagulopathies & Platelet Pathology 3.3 Hematologic Malignancies & Lymphoproliferative Disorders
4 Chapter 4: Behavioral Health & Psychiatric Disorders
4.1 Mood Disorders: Major Depression & Bipolar Spectrum 4.2 Anxiety, Trauma-Related & Somatic Symptom Disorders 4.3 Psychotic Disorders & Schizophrenia Spectrum 4.4 Substance Use Disorders & Psychopharmacology
5 Chapter 5: Nervous System & Special Senses
5.1 Cerebrovascular Disease, Stroke & Transients 5.2 Seizures, Epilepsy & Altered Mental Status 5.3 Movement Disorders, Dementia & Peripheral Neuropathies 5.4 Special Senses: Ophthalmologic & Otolaryngologic Emergencies
6 Chapter 6: Musculoskeletal System & Dermatology
6.1 Fractures, Dislocations & Orthopedic Trauma 6.2 Inflammatory Arthropathies & Crystal-Induced Diseases 6.3 Inflammatory & Infectious Dermatoses 6.4 Cutaneous Malignancies & Blistering Disorders
7 Chapter 7: Cardiovascular System
7.1 Coronary Artery Disease & Acute Coronary Syndromes 7.2 Heart Failure, Cardiomyopathies & Valvular Disease 7.3 Cardiac Arrhythmias, Conduction Blocks & EKG Interpretation 7.4 Vascular Emergencies: Aortic Aneurysms & Peripheral Arterial Disease
8 Chapter 8: Respiratory System
8.1 Obstructive Airway Diseases: Asthma & COPD 8.2 Infectious Pneumonias & Pleural Effusions 8.3 Pulmonary Vascular Disease & Thromboembolism 8.4 Acute Respiratory Distress Syndrome & Interstitial Lung Diseases
9 Chapter 9: Gastrointestinal System
9.1 Esophageal, Gastric & Peptic Ulcer Disorders 9.2 Inflammatory Bowel Disease & Colorectal Neoplasms 9.3 Hepatic Disorders, Cirrhosis & Portal Hypertension 9.4 Biliary Tract Diseases & Pancreatitis
10 Chapter 10: Renal, Urinary & Reproductive Systems
10.1 Acute Kidney Injury & Chronic Kidney Disease 10.2 Glomerular & Tubulointerstitial Diseases 10.3 Nephrolithiasis, Urinary Tract Infections & Prostate Pathology 10.4 Fluid, Electrolyte & Acid-Base Disorders 10.5 Female Reproductive Disorders & Gynecology 10.6 Breast Pathology & Clinical Breast Disease
11 Chapter 11: Pregnancy, Childbirth & Puerperium
11.1 Normal Prenatal Care & Maternal-Fetal Physiology 11.2 Medical & Obstetric Complications of Pregnancy 11.3 Labor, Delivery & Postpartum Management
12 Chapter 12: Endocrine System
12.1 Diabetes Mellitus, Hypoglycemia & Metabolic Emergencies 12.2 Thyroid & Parathyroid Disorders 12.3 Adrenal & Pituitary Axis Pathology
13 Chapter 13: Multisystem Processes & Critical Care
13.1 Shock States, Sepsis & Systemic Inflammatory Response 13.2 Environmental Emergencies, Toxicology & Overdose 13.3 Infectious Disease Principles & Systemic Pathogens
14 Chapter 14: Biostatistics, Epidemiology & Literature Interpretation
14.1 Study Designs, Bias & Validity 14.2 Diagnostic Testing: Sensitivity, Specificity, PPV & NPV 14.3 Statistical Significance, Risk Measures & Evidence-Based Medicine
15 Chapter 15: Social Sciences, Ethics & Systems-Based Practice
15.1 Medical Ethics, Informed Consent & Patient Autonomy 15.2 Legal Issues, Confidentiality & Surrogate Decision Making 15.3 Patient Safety, Quality Improvement & Medical Error Analysis 15.4 Health Care Delivery Systems, Interprofessional Care & Transitions
10.2 Glomerular & Tubulointerstitial Diseases
Key Takeaways Explain This Topic AI
Nephrotic syndrome is defined by heavy proteinuria (>3.5 g/24 h), hypoalbuminemia (<3.0 g/dL), peripheral edema, hyperlipidemia, and lipiduria (oval fat bodies/Maltese crosses).
Membranous nephropathy is the most common cause of nephrotic syndrome in adults, strongly associated with anti-phospholipase A2 receptor (PLA2R) antibodies, solid tumors, and a high risk of renal vein thrombosis.
Nephritic syndrome features hematuria with dysmorphic red blood cells and RBC casts, mild-to-moderate proteinuria (<3.5 g/24 h), oliguria, hypertension, and azotemia.
Acute Interstitial Nephritis (AIN) classically presents 7-14 days after starting a offending drug (NSAIDs, penicillins, cephalosporins, PPIs, sulfonamides) with the triad of fever, rash, and eosinophilia, plus urine eosinophiluria or WBC casts.
IgA nephropathy (Berger disease) causes recurrent macroscopic hematuria 1-2 days following an upper respiratory infection, whereas Post-Streptococcal Glomerulonephritis (PSGN) manifests 1-3 weeks after streptococcal pharyngitis/impetigo with low complement C3 levels.
Last updated: July 2026
Clinical Spectrum of Glomerular Disease
Glomerular diseases are categorized into nephrotic syndromes (podocyte damage resulting in non-inflammatory protein loss) and nephritic syndromes (endothelial and mesangial inflammation resulting in hematuria and renal function decline). On USMLE Step 2 CK, distinguishing between these patterns based on presentation, serologies, and biopsy findings is crucial. [ Glomerular Disease Suspected ]
- |
- [ 24-Hour Urine Protein & UA ]
- |
- +---------------------------+---------------------------+
- | |
- [ Proteinuria >3.5 g/24h ] [ Proteinuria <3.5 g/24h ]
- [ Hypoalbuminemia / Edema ] [ Hematuria / RBC Casts ]
- [ Hyperlipidemia / Lipiduria ] [ HTN / Oliguria / Azotemia ]
- | |
- (Nephrotic Syndrome) (Nephritic Syndrome)
- | |
- +------+------+ +------+------+
- | | | |
- [Pediatric] [Adult] [Normal C3] [Low C3]
- MCD FSGS / Membranous IgA Neph PSGN / MPGN
- Non-Inflammatory Nephrotic Syndromes
Nephrotic syndrome is defined by a characteristic pentad: (1) heavy proteinuria >3.5 g/24 hours (or spot urine protein-to-creatinine ratio >3.5), (2) hypoalbuminemia <3.0 g/dL , (3) generalized peripheral and periorbital edema, (4) hyperlipidemia, and (5) lipiduria featuring oval fat bodies that display a classic "Maltese cross" appearance under polarized light.
Nephrotic Condition Epidemiology / Associations Key Diagnostic & Biopsy Findings Management
Minimal Change Disease (MCD) Most common cause in children (80%); triggered by viral illness, immunization, or Hodgkin lymphoma Normal on light microscopy; effacement of podocyte foot processes on electron microscopy First-line Corticosteroids (prednisone) with excellent response
Focal Segmental Glomerulosclerosis (FSGS) Most common cause in African American adults; associated with HIV, heroin use, morbid obesity, sickle cell disease Segmental sclerosis involving subset of glomeruli; effacement of foot processes Corticosteroids, immunosuppressants, ACEi/ARBs
Membranous Nephropathy Most common cause in Caucasian adults; linked to anti-PLA2R antibodies , HBV/HCV, solid tumors (colon, lung), NSAIDs Light microscopy: GBM thickening ; Electron microscopy: "spike and dome" subepithelial deposits Immunosuppression (rituximab, cyclophosphamide + steroids)
Diabetic Nephropathy Leading cause of ESRD in the US; hyperfiltration followed by microalbuminuria (30-300 mg/day) Kimmelstiel-Wilson nodules (nodular glomerulosclerosis), GBM thickening ACE inhibitors or ARBs, SGLT2 inhibitors
Renal Amyloidosis Associated with Multiple Myeloma (AL) or chronic inflammation/RA (AA) Congo red stain showing apple-green birefringence under polarized light Treat underlying dyscrasia or inflammatory disorder
Major Complications of Nephrotic Syndrome
Hypercoagulability and Thrombosis : Urinary loss of antithrombin III , protein S, and protein C, combined with hyperfibrinogenemia, predisposes patients to deep vein thrombosis, pulmonary embolism, and renal vein thrombosis (most common in membranous nephropathy, presenting with acute flank pain, gross hematuria, and left-sided varicocele).
Increased Susceptibility to Infection : Loss of circulating immunoglobulins (IgG) and complement factors increases risk for bacterial peritonitis (spontaneous bacterial peritonitis caused by Streptococcus pneumoniae ) and sepsis.
Inflammatory Nephritic Syndromes & RPGN
Nephritic syndrome manifests with glomerular inflammation, resulting in breakdown of the glomerular basement membrane (GBM). Key features include dysmorphic red blood cells (RBCs), RBC casts , mild-to-moderate proteinuria (<3.5 g/24 h), oliguria, hypertension, and rising serum creatinine.
Nephritic Condition Key Clinical Features & Timing Laboratory & Serologic Findings Biopsy / Immunofluorescence
Post-Streptococcal Glomerulonephritis (PSGN) Occurs 1-3 weeks after Group A Strep pharyngitis or impetigo; presents with facial edema, cola-colored urine Low C3 complement ; positive Anti-streptolysin O (ASO) or anti-DNase B titers Subepithelial "humps" on EM; starry-sky granular IgG/C3 deposition
IgA Nephropathy (Berger Disease) Occurs 1-2 days (synpharyngitic) after upper respiratory or GI infection; recurrent episodic gross hematuria Normal serum complement (C3/C4); elevated serum IgA levels Mesangial IgA deposition on immunofluorescence
Rapidly Progressive Glomerulonephritis (RPGN) Rapid renal failure progression over days to weeks; causes pulmonary-renal syndromes Anti-GBM (+), p-ANCA/mpo-ANCA (+), or c-ANCA/pr3-ANCA (+) Crescent formation in Bowman's space (fibrin and macrophages)
Alport Syndrome Hereditary X-linked defect in Type IV collagen ; presents with hematuria, sensorineural hearing loss, ocular defects Normal complement levels; family history of early ESRD Basket-weave appearance of GBM on EM due to thinning and splitting
Subtypes of Rapidly Progressive Glomerulonephritis (RPGN)
Type 1 (Anti-GBM Disease / Goodpasture Syndrome) : Autoantibodies against alpha-3 chain of Type IV collagen. Linear IgG deposition along GBM. Presents with hemoptysis and glomerulonephritis. Managed with emergent plasmapheresis plus steroids and cyclophosphamide.
Type 2 (Immune Complex RPGN) : Progression of PSGN, Lupus Nephritis, or IgA Nephropathy. Granular pattern on immunofluorescence.
Type 3 (Pauci-Immune Vasculitis) : No antibody deposition on IF. Associated with ANCA positivity:
Granulomatosis with Polyangiitis (GPA) : PR3-ANCA / c-ANCA positive; upper respiratory (sinusitis, nasal bridge collapse), lower respiratory (cavitary pulmonary nodules), and renal involvement.
Microscopic Polyangiitis (MPA) : MPO-ANCA / p-ANCA positive; pulmonary capillaritis and necrotizing glomerulonephritis without granulomas.
Tubulointerstitial Diseases
Tubulointerstitial nephropathies involve non-glomerular inflammatory or ischemic damage primarily targeting the renal tubules and surrounding interstitium.
Acute Interstitial Nephritis (AIN)
Acute Interstitial Nephritis is an immunologically mediated hypersensitivity reaction occurring 7 to 14 days after exposure to an offending pharmacological agent. Common offending drugs include:
Antibiotics : Penicillins, cephalosporins, sulfonamides (TMP-SMX), ciprofloxacin, vancomycin, rifampin.
Nonsteroidal Anti-inflammatory Drugs (NSAIDs) : Ibuprofen, naproxen, celecoxib.
Proton Pump Inhibitors (PPIs) : Omeprazole, pantoprazole.
Classic Clinical Triad : (1) Fever, (2) Maculopapular skin rash, and (3) Peripheral eosinophilia. Urinalysis reveals white blood cells, WBC casts , and urine eosinophils (Hansel or Wright stain). Treatment requires immediate cessation of the offending drug; systemic corticosteroids are initiated if renal function does not quickly improve.
Renal Papillary Necrosis
Renal papillary necrosis involves ischemic necrosis of the renal papillae, presenting with gross hematuria, flank pain, and tissue sloughing into the urine (causing ureteral obstruction). High-yield causes are remembered by the mnemonic SAID :
S : Sickle cell disease or trait (microvascular occlusion due to sickling in hypoxic renal medulla).
A : Analgesic abuse (chronic ingestion of NSAIDs or acetaminophen combination products).
I : Infection (severe acute pyelonephritis).
D : Diabetes mellitus (microvascular disease).